Cimetidine treatment of protein-losing gastropathy (Ménétrier's disease). A clinical and pathophysiological study
Research output: Contribution to journal › Journal article › Research › peer-review
In a 47-year-old male with Ménétrier's disease (protein-losing gastropathy) the histamine-H2-receptor antagonist Cimetidine stops the protein loss and improves the clinical condition. Gastric perfusion studies on net and bidirectional ionic fluxes, protein secretion rates, and permeability, with simultaneous recording of the transmural electrical potential difference indicate that Cimetidine decreases a paracellular protein secretion by 'tightening' the tight junctions of the gastric epithelium.
Original language | English |
---|---|
Journal | Scandinavian Journal of Gastroenterology |
Volume | 13 |
Issue number | 5 |
Pages (from-to) | 636-9 |
Number of pages | 3 |
ISSN | 0036-5521 |
Publication status | Published - 1978 |
Bibliographical note
Keywords: Cimetidine; Guanidines; Humans; Intestinal Absorption; Male; Membrane Potentials; Middle Aged; Protein-Losing Enteropathies; Proteins; Water-Electrolyte Balance
ID: 19398750